IL147201A0 - Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug response - Google Patents

Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug response

Info

Publication number
IL147201A0
IL147201A0 IL14720100A IL14720100A IL147201A0 IL 147201 A0 IL147201 A0 IL 147201A0 IL 14720100 A IL14720100 A IL 14720100A IL 14720100 A IL14720100 A IL 14720100A IL 147201 A0 IL147201 A0 IL 147201A0
Authority
IL
Israel
Prior art keywords
anticoagulant
surrogate markers
patient
treating
prevent
Prior art date
Application number
IL14720100A
Other languages
English (en)
Original Assignee
Rxfiles Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rxfiles Corp filed Critical Rxfiles Corp
Publication of IL147201A0 publication Critical patent/IL147201A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Radiation-Therapy Devices (AREA)
  • Electrotherapy Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Accommodation For Nursing Or Treatment Tables (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14720100A 1999-07-06 2000-07-06 Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug response IL147201A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/348,592 US6267116B1 (en) 1999-07-06 1999-07-06 Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
PCT/US2000/018576 WO2001002050A2 (en) 1999-07-06 2000-07-06 Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug response

Publications (1)

Publication Number Publication Date
IL147201A0 true IL147201A0 (en) 2002-08-14

Family

ID=23368686

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14720100A IL147201A0 (en) 1999-07-06 2000-07-06 Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug response

Country Status (15)

Country Link
US (2) US6267116B1 (de)
EP (1) EP1191894B1 (de)
JP (1) JP2003503165A (de)
KR (1) KR20020036790A (de)
CN (1) CN1359276A (de)
AT (1) ATE378015T1 (de)
AU (1) AU5919800A (de)
BR (1) BR0012241A (de)
CA (1) CA2362429C (de)
DE (1) DE60037116T2 (de)
IL (1) IL147201A0 (de)
MX (1) MXPA01013306A (de)
NO (2) NO20020043D0 (de)
TR (1) TR200103831T2 (de)
WO (1) WO2001002050A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6575169B2 (en) * 1999-07-06 2003-06-10 The Rxfiles Corporation Method and apparatus for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
US6581607B2 (en) * 1999-07-06 2003-06-24 The Rx Files Corporation Method and system for use in treating a patient with a biological substance to optimize therapy and prevent an adverse response
US6267116B1 (en) * 1999-07-06 2001-07-31 The Rxfiles Corporation Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
US6581606B2 (en) * 1999-07-06 2003-06-24 The Rx Files Corporation Method, apparatus and system for use in treating patient with a drug having an antineoplastic effect to optimize therapy and prevent an adverse drug response
EP1311202A4 (de) * 2000-08-24 2007-04-18 Dimensional Dosing Systems Inc Verfahren und vorrichtung zur revision der antikoagulantdosis
US6578582B2 (en) * 2001-08-24 2003-06-17 The Rxfiles Corporation Method and apparatus using IDS™ for multi-agent therapy
US6883521B2 (en) * 2001-08-24 2005-04-26 Dimensional Dosing Systems, Inc. Method and apparatus for dosing single and multi-agent therapy
WO2003026727A1 (en) * 2001-09-28 2003-04-03 Lifevent Limited sETHOD AND APPARATUS FOR DELIVERY OF MEDICATION
US20050154537A1 (en) * 2003-12-12 2005-07-14 Kutzko John D. Methods, program products, and systems for single and multi-agent dosing and other related methods
PL1862233T3 (pl) * 2006-06-01 2011-07-29 Wila Bv Narzędzie z automatycznym zatrzaskiem zabezpieczającym
EP1862255B1 (de) * 2006-06-01 2011-03-16 Wila B.V. Auswechselbares Werkzeug/Manipulator Kombination
US20090216561A1 (en) * 2008-02-22 2009-08-27 Swedish Health Services Methods for management of anticoagulation therapy
US8112290B2 (en) * 2008-05-16 2012-02-07 Adolor Corporation Methods for delivering a drug to a hospital patient for short-term use while minimizing long-term use of the drug
ES2927105T3 (es) * 2008-10-20 2022-11-02 Epitome Pharmaceuticals Ltd Métodos y sistemas para mejorar la intervención farmacéutica en el control de la coagulación
WO2011163506A2 (en) 2010-06-23 2011-12-29 University Of Louisville Research Foundation, Inc. Methods and kits for predicting a response to an erythropoietic agent
US9852267B2 (en) 2011-09-30 2017-12-26 University Of Louisville Research Foundation, Inc. System and method for personalized dosing of pharmacologic agents
US10083400B2 (en) 2012-10-05 2018-09-25 Diane R. MOULD System and method for providing patient-specific dosing as a function of mathematical models updated to account for an observed patient response
AU2016245862A1 (en) 2015-04-09 2018-02-22 Diane R. Mould Systems and methods for patient-specific dosing
US20190043501A1 (en) * 2017-08-02 2019-02-07 Elements of Genius, Inc. Patient-centered assistive system for multi-therapy adherence intervention and care management
US12046341B2 (en) * 2021-10-05 2024-07-23 Bradford Rabin Methods and systems for electronically adjusting a dosing pattern of a patient undergoing a medical regimen
KR20240033436A (ko) 2022-09-05 2024-03-12 박세경 휴대용 머신러닝 기반의 약물 부작용 탐지 시스템
US12295943B2 (en) 2023-09-22 2025-05-13 Closed Loop Medicine Ltd Apixaban dosing

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5694950A (en) * 1992-08-21 1997-12-09 J & W Mcmichael Software, Inc. Method and system for use in treating a patient with immunosuppresants using whole blood level criteria to prevent an adverse immune response
US5365948A (en) * 1992-08-21 1994-11-22 J & W Mcmichael Software Inc. Method for use in treating a patient with FK 506 to prevent an adverse immune response
US6581607B2 (en) * 1999-07-06 2003-06-24 The Rx Files Corporation Method and system for use in treating a patient with a biological substance to optimize therapy and prevent an adverse response
US6581606B2 (en) * 1999-07-06 2003-06-24 The Rx Files Corporation Method, apparatus and system for use in treating patient with a drug having an antineoplastic effect to optimize therapy and prevent an adverse drug response
US6267116B1 (en) * 1999-07-06 2001-07-31 The Rxfiles Corporation Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
US6575169B2 (en) * 1999-07-06 2003-06-10 The Rxfiles Corporation Method and apparatus for use in treating a patient with any drug to optimize therapy and prevent an adverse drug

Also Published As

Publication number Publication date
MXPA01013306A (es) 2002-07-02
NO20020056D0 (no) 2002-01-07
CN1359276A (zh) 2002-07-17
US6267116B1 (en) 2001-07-31
DE60037116T2 (de) 2008-09-11
JP2003503165A (ja) 2003-01-28
TR200103831T2 (tr) 2002-10-21
ATE378015T1 (de) 2007-11-15
WO2001002050A2 (en) 2001-01-11
EP1191894A4 (de) 2004-10-20
NO20020043D0 (no) 2002-01-04
AU5919800A (en) 2001-01-22
CA2362429A1 (en) 2001-01-11
BR0012241A (pt) 2002-03-26
CA2362429C (en) 2005-07-05
KR20020036790A (ko) 2002-05-16
US6942614B1 (en) 2005-09-13
EP1191894A2 (de) 2002-04-03
WO2001002050A3 (en) 2002-01-10
NO20020056L (no) 2002-01-07
EP1191894B1 (de) 2007-11-14
DE60037116D1 (de) 2007-12-27

Similar Documents

Publication Publication Date Title
IL147201A0 (en) Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug response
DE60040698D1 (de) Stimulationssystem
NO996229D0 (no) Heparanase spesifikke molekylaere prober og deres anvendelse i forskning og medisin
SE8105081L (sv) System for behovsbaserad administration av insulin
DE60011274D1 (de) Verfahren, reagenz und messkartusche zur bestimmung der gerinnungszeit
TW365526B (en) Relaxation aiding device and biological feedback aiding device
DE69802428D1 (de) Verfahren und gerät zur verminderung von alarmmisständen
WO2003011215A3 (en) Method and system to determine revised dosage
BR0017048A (pt) Pró-drogas de bisamidato fosfonato
DE59009462D1 (de) Implantierbare Vorrichtung zur dosierten Abgabe von Medikamenten in den menschlichen Körper.
WO2002082972A3 (en) Method and apparatus to optimize drug therapy
DE69925957D1 (de) Vorrichtung zur pulsartigen Verabreichung von Stickoxid mit genauer Dosis sowie Überwachunggerät und Alarmanlagen
CY1107640T1 (el) Μεθοδος για πιστοποιηση παραγοντων για τη θεραπεια διαβητη
DE69333641D1 (de) Methode zur messung der knochenresorption
ATE132757T1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
EP1162457A3 (de) Vielfach-Koagulationstestsystem und Verfahren zu seiner Anwendung
DE69718169D1 (de) Test zur diagnose von schizophrenie mittels niacin
PT87997A (pt) Processo para a preparacao de composicoes farmaceuticas uteis para a correccao de vias metabolicas aberrantes associadas com ciclos de crescimento descontrolados de celulas tumorais e de virus contendo arn de dupla cadeia
DK0568554T3 (da) Fremgangsmåde til påvisning af anti-RNA-antistoffer
ES2095337T3 (es) Preparacion de pranoprofen de liberacion sostenida.
FI973424L (fi) Menetelmä ja järjestelmä potilasvalvonnan yhteydessä
ATE126437T1 (de) Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.
ES2077698T3 (es) Agente terapeutico para la gangrena diabetica.
EA200100539A1 (ru) Новый способ лечения
DUPEU The sterilizing action of a gaseous formol: Use of a chamber equipped with a ventilation system